Toxic Alcohol Ingestions: Clinical Features, Diagnosis, and Management
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Alcohol Intoxication Withdrawal Adult
Provincial Clinical Knowledge Topic Alcohol Intoxication Withdrawal, Adult Emergency Department V 1.5 © 2018, Alberta Health Services. This work is licensed under the Creative Commons Attribution-Non-Commercial-No Derivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Disclaimer: This material is intended for use by clinicians only and is provided on an "as is", "where is" basis. Although reasonable efforts were made to confirm the accuracy of the information, Alberta Health Services does not make any representation or warranty, express, implied or statutory, as to the accuracy, reliability, completeness, applicability or fitness for a particular purpose of such information. This material is not a substitute for the advice of a qualified health professional. Alberta Health Services expressly disclaims all liability for the use of these materials, and for any claims, actions, demands or suits arising from such use. Document History Version Date Description of Revision Completed By / Revised By 1.1 July 2015 Completed document (2013) reformatted into Dr. Bullard / Carla new topic template Milligan 1.2 January Minor edits in the Rationale section and form 1 Dr. Bullard / Sarah 2016 info in general care section as well as addition Searle of CIWA-Ar Scoring Reference tool to appendix 1.3 May 2016 Minor edits made to working group Sarah Searle membership list 1.4 June Removed link to Center for Addiction and Dr. Bullard / Sarah 2017 Mental Health assessment and documentation Searle form on pg. 35. Documentation requirements will continue as per local practice at this time. -
Severe Metabolic Acidosis in a Patient with an Extreme Hyperglycaemic Hyperosmolar State: How to Manage? Marloes B
Clinical Case Reports and Reviews Case Study ISSN: 2059-0393 Severe metabolic acidosis in a patient with an extreme hyperglycaemic hyperosmolar state: how to manage? Marloes B. Haak, Susanne van Santen and Johannes G. van der Hoeven* Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, the Netherlands Abstract Hyperglycaemic hyperosmolar state (HHS) and diabetic ketoacidosis (DKA) are often accompanied by severe metabolic and electrolyte disorders. Analysis and treatment of these disorders can be challenging for clinicians. In this paper, we aimed to discuss the most important steps and pitfalls in analyzing and treating a case with extreme metabolic disarrangements as a consequence of an HHS. Electrolyte disturbances due to fluid shifts and water deficits may result in potentially dangerous hypernatriema and hyperosmolality. In addition, acid-base disorders often co-occur and several approaches have been advocated to assess the acid-base disorder by integration of the principles of mass balance and electroneutrality. Based on the case vignette, four explanatory methods are discussed: the traditional bicarbonate-centered method of Henderson-Hasselbalch, the strong ion model of Stewart, and its modifications ‘Stewart at the bedside’ by Magder and the simplified Fencl-Stewart approach. The four methods were compared and tested for their bedside usefulness. All approaches gave good insight in the metabolic disarrangements of the presented case. However, we found the traditional method of Henderson-Hasselbalch and ‘Stewart at the bedside’ by Magder most explanatory and practical to guide treatment of the electrolyte disturbances and in exploring the acid-base disorder of the presented case. Introduction This is accompanied by changes in pCO2 and bicarbonate (HCO₃ ) levels, depending on the cause of the acid-base disorder. -
Toxicology and Environmental Teaching Tue 1St Oct 2019
TOXICOLOGY AND ENVIRONMENTAL TEACHING TUE 1ST OCT 2019 CASE ONE The ambulance bring in a 50 year old woman who has been found confused at her home by friends. There is no history available, but she was last seen well around dinner yesterday. She has no known past history and her medications are unknown. Initial Obs: - GCS M 5, E4, V4 pupils large and reactive - SBP 110 - HR 120 - Sats 99% o/a - Afebrile - BSL 8 1. She is confused and denies any ingestion or overdose. She dose state she only took some sleeping medication. What investigations would you do and how would you manage her presentation? Look up NHI: prior hx, community dispensing etc Investigations: Bloods, VBG, ECG Consider differential diagnoses : sepsis, trauma, metabolic 2. You note a community dispensing for 60 x 20mg amitriptyline tablets a few days ago. Her ECG and VBG are shown, please describe and discuss the findings: Potential toxic dose > 10mg/kg onset, toxicity usually rapid onset in 1- 2hrs VBG pH 7.35 PCO2 4.0 HCO3 15 Na 143 K 4.2 Lactate 3.5 - Sinus tachycardia with first-degree AV block (P waves hidden in the T waves, best seen in V1-2). - Broad QRS complexes. - Positive R’ wave in aVR. ECG Features of Sodium-Channel Blockade Interventricular conduction delay — QRS > 100 ms in lead II Right axis deviation of the terminal QRS: o Terminal R wave > 3 mm in aVR o R/S ratio > 0.7 in aVR Patients with tricyclic overdose will also usually demonstrate sinus tachycardia secondary to muscarinic (M1) receptor blockade. -
The Effects of Ethanol on Ketone Body Metabolism of Fasted Rats Henry S
Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1975 The effects of ethanol on ketone body metabolism of fasted rats Henry S. Cabin Yale University Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Recommended Citation Cabin, Henry S., "The effects of ethanol on ketone body metabolism of fasted rats" (1975). Yale Medicine Thesis Digital Library. 2432. http://elischolar.library.yale.edu/ymtdl/2432 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. YALE MEDICAL LIBRARY YALE MEDICAL LIBRARY Digitized by the Internet Archive in 2017 with funding from The National Endowment for the Humanities and the Arcadia Fund https://archive.org/details/effectsofethanolOOcabi The Effects of Ethanol on Ketone Body Metabolism of Fasted Rats by Henry S, Cabin B.A. University of Pennsylvania, 1971 Presented in partial fulfillment of the requirements for the degree of Doctor of Medicine, Yale University School of Medicine -March, 1975- ACKNOWLEDGEMENTS To Dr. Felig- who.has guided me through this research project from its inception, and for whom I have the highest esteem as a teacher, physician and human being. To Rosa, Bill and Andrea- without whose support and assistance this project would never have come to fruition. -
Alcoholic Ketoacidosis
Alcoholic Ketoacidosis: Mind The Gap, Give Them What They Need Brendan Innes BS, Stephanie Carreiro MD University of Massachusetts Medical School, Department of Emergency Medicine Introduction Differential Diagnosis Case Discussion Pancreatitis, Alcohol induced gastritis, Alcohol withdrawal, Diagnostic Criteria for Alcoholic Ketoacidosis2,3 • Patients with alcohol use disorder commonly present to the ED Alcohol induced hepatitis, Acute Kidney Injury, Sepsis, Binge drinking ending in nausea, vomiting, and decreased intake critically ill due to a myriad of underlying pathologies. Metabolic abnormality (Alcoholic ketoacidosis), Acute coronary syndrome, Pulmonary embolism Wide anion gap metabolic acidosis without alternate explanation • Alcoholic ketoacidosis (AKA) should be considered in anyone Clinical Data Positive serum/urine ketones with prolonged and/or binge consumption of alcohol. Low, normal, or slightly elevated serum glucose Anion Gap 36 130 83 27 Urinalysis Core Emergency Medicine Principles • Diagnosis and proper treatment results in rapid correction of 167 Lactate 1.9 5 11 1.9 Protein 2+ • Treatment for AKA requires glucose administration, thiamine underlying metabolic derangements often followed by rapid Salicylate, ethylene glycol, Ketones 3+ supplementation, and volume repletion. methanol not detected Urobilinogen + • D5 NS IV until rehydrated, D5 1/2NS for maintenance. clinical improvement. 16.6 Digoxin: 0.3 ng/mL 17.2 241 RBCs 5/hpf • Thiamine 100 mg IV before glucose. • Failure to make the diagnosis can result in shock, hypokalemia, 49.3 PT/INR: >120/>11 Hyaline casts 21 • Supplement electrolytes PRN. VBG: pH 7.34, pCO2 25 • Continue treatment until anion gap closes, oral intake tolerated. 90% PMNs /hpf hypoglycemia, and acidosis. • Consider other causes of anion gap if gap does not close with Neutrophils 15.6x103/µL BNP: 66 pc/mL UTox: caffeine Trop: 0.1 ng/mL treatment Lipase: 13 U/L Case Description EKG: sinus tach • Consider sodium bicarbonate if despite treatment pH < 7.0. -
Diabetic Ketoacidosis
PRIMER Diabetic ketoacidosis Ketan K. Dhatariya1,2, Nicole S. Glaser3, Ethel Codner4 and Guillermo E. Umpierrez5 ✉ Abstract | Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present — ‘D’, either elevated blood glucose levels or a family history of diabetes mellitus; ‘K’, the presence of high urinary or blood ketoacids; and ‘A’, a high anion gap metabolic acidosis. Early diagnosis and management are paramount to improve patient outcomes. The mainstays of treatment include restoration of circulating volume, insulin therapy , electrolyte replacement and treatment of any underlying precipitating event. Without optimal treatment, DKA remains a condition with appreciable, although largely preventable, morbidity and mortality. In this Primer, we discuss the epidemiology , pathogenesis, risk factors and diagnosis of DKA and provide practical recommendations for the management of DKA in adults and children. Circulatory volume Diabetic ketoacidosis (DKA) is the most common acute acid decarboxylase and protein tyrosine phosphatase depletion hyperglycaemic emergency in people with diabetes mel- autoantibodies, as those who present with hyperosmo- A reduction in intravascular litus. DKA is the consequence of an absolute (that is, lar hyperglycaemic state (HHS), and their β-cell func- and/or extracellular fluid total absence of) or relative (that is, levels insufficient tion recovers with restoration of insulin secretion quickly volume, such that there may 2 be an inability to adequately to supress ketone production) lack of insulin and con- after treatment . Thus, individuals with ketosis-prone perfuse tissue. comitant elevation of counter-regulatory hormones, T2DM can often go back to oral glucose-lowering medi- usually resulting in the triad of hyperglycaemia, met- cation without the need for continuing insulin therapy. -
1 Effects of a Ketone-Caffeine Supplement on Cycling And
Effects of A Ketone-Caffeine Supplement On Cycling and Cognitive Performance in Chronic Keto-Adapted Participants THESIS Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in the Graduate School of The Ohio State University By Madison Lee Bowling Graduate Program in Kinesiology The Ohio State University 2018 Thesis Committee Dr. Jeff Volek Dr. William Kraemer Dr. Carl Maresh 1 Copyrighted by Madison Lee Bowling 2018 2 Abstract As research begins to broaden our understanding of the effects of low carbohydrate, high fat ketogenic diets to different populations, it is crucial to utilize evidence associated with the metabolic and physiological adaptation of chronic implementation. Specific populations are finding that nutritional ketosis may prove advantageous to athletic or cognitive performance. Nutritional ketosis may be identified by an elevated plasma ketone concentration within the blood range 0.5 to 5 mmol/L that results from a chronic implementation of a ketogenic diet. Recently, science shows that ketones contribute to a vast range of therapeutic and performance benefits associated with nutritional ketosis, as a result, exogenous ketone supplements have become commercially available which have proven to induce acute nutritional ketosis without restriction of carbohydrate intake. We previously showed that a supplement containing ketone salts and caffeine significantly increased performance in a non-keto adapted population. To date, there are no reports of whether ketone supplements have an ergogenic effect in an already keto-adapted population. The primary purpose of this study was to determine the performance and metabolic effects of a supplement containing ketone salts and caffeine in a group of people habituated to a ketogenic diet. -
Reporting Terminology and Codes Chemical Pathology (V3.0)
Standards for Pathology Informatics in Australia (SPIA) Reporting Terminology and Codes Chemical Pathology (v3.0) Superseding and incorporating the Australian Pathology Units and Terminology Standards and Guidelines (APUTS) ISBN: Pending State Health Publication Number (SHPN): Pending Online copyright © RCPA 2017 This work (Standards and Guidelines) is copyright. You may download, display, print and reproduce the Standards and Guidelines for your personal, non- commercial use or use within your organisation subject to the following terms and conditions: 1. The Standards and Guidelines may not be copied, reproduced, communicated or displayed, in whole or in part, for profit or commercial gain. 2. Any copy, reproduction or communication must include this RCPA copyright notice in full. 3. No changes may be made to the wording of the Standards and Guidelines including commentary, tables or diagrams. Excerpts from the Standards and Guidelines may be used. References and acknowledgments must be maintained in any reproduction or copy in full or part of the Standards and Guidelines. Apart from any use as permitted under the Copyright Act 1968 or as set out above, all other rights are reserved. Requests and inquiries concerning reproduction and rights should be addressed to RCPA, 207 Albion St, Surry Hills, NSW 2010, Australia. This material contains content from LOINC® (http://loinc.org). The LOINC table, LOINC codes, LOINC panels and forms file, LOINC linguistic variants file, LOINC/RSNA Radiology Playbook, and LOINC/IEEE Medical Device Code Mapping Table are copyright © 1995-2016, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/terms-of-use.” This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO®). -
Alcohol Withdrawal
Alcohol withdrawal TERMINOLOGY CLINICAL CLARIFICATION • Alcohol withdrawal may occur after cessation or reduction of heavy and prolonged alcohol use; manifestations are characterized by autonomic hyperactivity and central nervous system excitation 1, 2 • Severe symptom manifestations (eg, seizures, delirium tremens) may develop in up to 5% of patients 3 CLASSIFICATION • Based on severity ○ Minor alcohol withdrawal syndrome 4, 5 – Manifestations occur early, within the first 48 hours after last drink or decrease in consumption 6 □ Manifestations develop about 6 hours after last drink or decrease in consumption and usually peak about 24 to 36 hours; resolution occurs in 2 to 7 days 7 if withdrawal does not progress to major alcohol withdrawal syndrome 4 – Characterized by mild autonomic hyperactivity (eg, tachycardia, hypertension, diaphoresis, hyperreflexia), mild tremor, anxiety, irritability, sleep disturbances (eg, insomnia, vivid dreams), gastrointestinal symptoms (eg, anorexia, nausea, vomiting), headache, and craving alcohol 4 ○ Major alcohol withdrawal syndrome 5, 4 – Progression and worsening of withdrawal manifestations, usually after about 24 hours from the onset of initial manifestations 4 □ Manifestations often peak around 50 hours before gradual resolution or may continue to progress to severe (complicated) withdrawal, particularly without treatment 4 – Characterized by moderate to severe autonomic hyperactivity (eg, tachycardia, hypertension, diaphoresis, hyperreflexia, fever); marked tremor; pronounced anxiety, insomnia, -
IFCC Curriculum
The IFCC Curriculum AUTHORS: R. Greaves, J. M. Smith SECTION AUTHORS: R. Greaves, C Florkowski, L. Langman, J. Sheldon The IFCC Curriculum was developed as part of the IFCC eAcademy project by the Committee for Distance Learning. Authors: Janet M Smith [email protected] Ronda Greaves School of Health and Biomedical Sciences - RMIT University, PO Box 71, Bundoora, Victoria 3083 Australia [email protected] Section authors: Evidence Based Laboratory Medicine Section Chris Florkowski Clinical Biochemistry Unit, Canterbury Health Laboratories, PO Box 151, Christchurch, New Zealand [email protected] Immunology Section Jo Sheldon Protein Reference Unit, St. George's Hospital, Blackshaw Road, London SW17 0NH - UK [email protected] Mass Spectrometry Section Ronda Greaves School of Health and Biomedical Sciences - RMIT University, PO Box 71, Bundoora, Victoria 3083 Australia [email protected] Loralie Langman Department of Laboratory Medicine and Pathology Mayo Clinic 200 2nd Street SW Rochester, MN 55905 USA [email protected] Contacts: [email protected] _________________________________________ The IFCC Curriculum - Rev 0 - December 2017 (effective until further revision) 1 Contents INTRODUCTION .................................................................................................................................. 4 SECTION A: Laboratory Organisation and Management .......................................................... 9 Section A1: Laboratory Principles and Procedures: Learning Objectives ...................... -
BMC Emergency Medicine Biomed Central
BMC Emergency Medicine BioMed Central Research article Open Access An evaluation of the osmole gap as a screening test for toxic alcohol poisoning Larry D Lynd*†1,2, Kathryn J Richardson†2, Roy A Purssell†3,4,5, Riyad B Abu- Laban†3,6, Jeffery R Brubacher†3,4,5, Katherine J Lepik†4 and Marco LA Sivilotti†7 Address: 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 2Centre for Health Evaluation and Outcomes Sciences, Providence Health Care, Vancouver, Canada, 3Department of Emergency Medicine, Vancouver General Hospital, Vancouver, Canada, 4British Columbia Drug and Poison Information Centre, Provincial Health Services Authority of BC, Vancouver, Canada, 5Division of Emergency Medicine, Dept. of Surgery, Faculty of Medicine, University of British Columbia; Vancouver; Canada, 6Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, Canada and 7Departments of Emergency Medicine and of Pharmacology & Toxicology, Queen's University, Kingston, Canada; and Ontario Poison Centre, Toronto, Canada Email: Larry D Lynd* - [email protected]; Kathryn J Richardson - [email protected]; Roy A Purssell - [email protected]; Riyad B Abu-Laban - [email protected]; Jeffery R Brubacher - [email protected]; Katherine J Lepik - [email protected]; Marco LA Sivilotti - [email protected] * Corresponding author †Equal contributors Published: 28 April 2008 Received: 12 April 2007 Accepted: 28 April 2008 BMC Emergency Medicine 2008, 8:5 doi:10.1186/1471-227X-8-5 This article is available from: http://www.biomedcentral.com/1471-227X/8/5 © 2008 Lynd et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Alcohol Use Disorder
Alcohol use disorder Description Alcohol use disorder is a diagnosis made when an individual has severe problems related to drinking alcohol. Alcohol use disorder can cause major health, social, and economic problems, and can endanger affected individuals and others through behaviors prompted by impaired decision-making and lowered inhibitions, such as aggression, unprotected sex, or driving while intoxicated. Alcohol use disorder is a broad diagnosis that encompasses several commonly used terms describing problems with drinking. It includes alcoholism, also called alcohol addiction, which is a long-lasting (chronic) condition characterized by a powerful, compulsive urge to drink alcohol and the inability to stop drinking after starting. In addition to alcoholism, alcohol use disorder includes alcohol abuse, which involves problem drinking without addiction. Habitual excessive use of alcohol changes the chemistry of the brain and leads to tolerance, which means that over time the amount of alcohol ingested needs to be increased to achieve the same effect. Long-term excessive use of alcohol may also produce dependence, which means that when people stop drinking, they have physical and psychological symptoms of withdrawal, such as sleep problems, irritability, jumpiness, shakiness, restlessness, headache, nausea, sweating, anxiety, and depression. In severe cases, agitation, fever, seizures, and hallucinations can occur; this pattern of severe withdrawal symptoms is called delirium tremens. The heavy drinking that often occurs in alcohol use disorder, and can also occur in short- term episodes called binge drinking, can lead to a life-threatening overdose known as alcohol poisoning. Alcohol poisoning occurs when a large quantity of alcohol consumed over a short time causes problems with breathing, heart rate, body temperature, and the gag reflex.